Nasser Ud-din Khan , MD

Specialty

Cardiovascular Disease (cardiology)

Gender

M

Medical School

Other

Graduation Year

1988

Offers Telehealth Services

Yes

Accepts Medicare Assignment

Yes

Facility Type

Hospital

Facility

Facility Type

Hospital

Facility

Facility Type

Hospital

Facility

Facility Type

Hospital

Facility

Facility Type

Hospital

Facility

Facility Type

Group

Group Name

Member Count

10

Accepts Medicare Assignment

Y

Procedure Category

Coronary angioplasty and stenting

Count

58

Percentile

76

Procedure Category

Pacemaker insertion or repair

Count

14

Percentile

66

MIPS Measure

Use of certified EHR to capture patient reported outcomes

Attestation

Yes

MIPS Measure

Implementation of Use of Specialist Reports Back to Referring Clinician or Group to Close Referral Loop

Attestation

Yes

MIPS Measure

Implementation of practices/processes for developing regular individual care plans

Attestation

Yes

MIPS Measure

Use of telehealth services that expand practice access

Attestation

Yes

MIPS Measure

Anticoagulant Management Improvements

Attestation

Yes

MIPS Measure

Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)

Attestation

No

MIPS Measure

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Attestation

No

MIPS Measure

Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Attestation

No

MIPS Measure

Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)

Attestation

No

MIPS Measure

Coronary Artery Disease (CAD): Antiplatelet Therapy

Attestation

No

MIPS Measure

Advance Care Plan

Attestation

No

MIPS Measure

Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)

Attestation

No

MIPS Measure

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan

Attestation

No

MIPS Measure

Documentation of Current Medications in the Medical Record

Attestation

No

MIPS Measure

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

Attestation

No

MIPS Measure

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

Attestation

No

MIPS Measure

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

Attestation

No

MIPS Measure

Cardiac Rehabilitation Patient Referral from an Outpatient Setting

Attestation

No

MIPS Measure

Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy

Attestation

No

MIPS Measure

Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)

Attestation

No

MIPS Measure

e-Prescribing

Attestation

No

MIPS Measure

ONC-ACB Surveillance Attestation

Attestation

Yes

MIPS Measure

ONC Direct Review Attestation

Attestation

Yes

MIPS Measure

Provide Patients Electronic Access to Their Health Information

Attestation

No

MIPS Measure

Electronic Case Reporting

Attestation

Yes

MIPS Measure

Clinical Data Registry Reporting

Attestation

Yes

MIPS Measure

Security Risk Analysis

Attestation

Yes

MIPS Measure

Peripheral Artery Disease: Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk

Attestation

No